Company
Resurge Therapeutics Inc.
Resurge Therapeutics Inc. has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| RT-310 | Phase 2 | Benign Prostatic Hyperplasia (BPH) |
Latest
No recent events.
Follow Resurge Therapeutics Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.